TIL Desk/Business/Washington/ India, a global hub for generic drugs, has launched a new scheme to boost production of active pharmaceutical ingredients that are greatly dependent on the Chinese supply chain, according to NITI Aayog CEO Amitabh Kant.
Speaking at the 14th Annual BioPharma and Healthcare Summit, he said India is now gearing up for innovation in its pharmaceutical ecosystem focusing on speedy and scaled up delivery of new vaccines and personalised medicines.
He said that India has launched a new scheme to boost production of active pharmaceutical ingredients that are greatly dependent on the Chinese supply chain. “We are planning to do complete manufacturing in India,” he said at the virtual summit organised by the USA-India Chamber of Commerce on Friday.
Related Posts
पैरासिटामोल समेत 53 दवाएं क्वालिटी चेक में फेल, CDSCO रिपोर्ट में बड़ा खुलासा
